FDA advisors say no to MDMA. What’s the impact? With Josh Hardman
Business Trip
Navigating Drug Approval and Cost-Effective Healthcare Innovations
This chapter delves into the intricate drug approval processes of pharmaceutical companies and their impact on approval outcomes. It also emphasizes the role of integrated healthcare systems in Europe and the UK in promoting cost-effective, innovative studies to alleviate patient burdens.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
